105 related articles for article (PubMed ID: 23354097)
21. Rabbit slow and fast skeletal muscle-derived satellite myoblast phenotypes do not involve constitutive differences in the components of the insulin-like growth factor system.
Barjot C; Navarro M; Cotten ML; Garandel V; Bernardi H; Bacou F; Barenton B
J Cell Physiol; 1996 Nov; 169(2):227-34. PubMed ID: 8908189
[TBL] [Abstract][Full Text] [Related]
22. Mechanistic Target of Rapamycin Complex 1 Signaling Links Hypoxia to Increased IGFBP-1 Phosphorylation in Primary Human Decidualized Endometrial Stromal Cells.
Nandi P; Jang CE; Biggar K; Halari CD; Jansson T; Gupta MB
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572595
[TBL] [Abstract][Full Text] [Related]
23. Structural and functional characteristics of the Val44Met insulin-like growth factor I missense mutation: correlation with effects on growth and development.
Denley A; Wang CC; McNeil KA; Walenkamp MJ; van Duyvenvoorde H; Wit JM; Wallace JC; Norton RS; Karperien M; Forbes BE
Mol Endocrinol; 2005 Mar; 19(3):711-21. PubMed ID: 15576456
[TBL] [Abstract][Full Text] [Related]
24. Role of N- and C-terminal residues of insulin-like growth factor (IGF)-binding protein-3 in regulating IGF complex formation and receptor activation.
Yan X; Forbes BE; McNeil KA; Baxter RC; Firth SM
J Biol Chem; 2004 Dec; 279(51):53232-40. PubMed ID: 15485880
[TBL] [Abstract][Full Text] [Related]
25. The insulin-like growth factor (IGF)binding protein 1 binding epitope on IGF-I probed by heteronuclear NMR spectroscopy and mutational analysis.
Jansson M; Andersson G; Uhlén M; Nilsson B; Kördel J
J Biol Chem; 1998 Sep; 273(38):24701-7. PubMed ID: 9733769
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: topographical evaluation of the IGF-1/IGFBP-2 AND IGFBP-3 interface.
Robinson SA; Rosenzweig SA
Biochemistry; 2004 Sep; 43(36):11533-45. PubMed ID: 15350139
[TBL] [Abstract][Full Text] [Related]
27. The divergent effect of insulin-like growth factor binding protein (IGFBP) - 1 on IGF-induced Steroidogenesis in bovine adrenocortical cells is not due to its phosphorylation status.
Fottner C; Spöttl G; Weber MM
Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):232-9. PubMed ID: 17479439
[TBL] [Abstract][Full Text] [Related]
28. Effect of IGFBP-3 on IGF- and IGF-analogue-induced insulin-like growth factor-I receptor (IGFIR) signalling.
Devi GR; Graham DL; Oh Y; Rosenfeld RG
Growth Horm IGF Res; 2001 Aug; 11(4):231-9. PubMed ID: 11735239
[TBL] [Abstract][Full Text] [Related]
29. Liver mTOR controls IGF-I bioavailability by regulation of protein kinase CK2 and IGFBP-1 phosphorylation in fetal growth restriction.
Abu Shehab M; Damerill I; Shen T; Rosario FJ; Nijland M; Nathanielsz PW; Kamat A; Jansson T; Gupta MB
Endocrinology; 2014 Apr; 155(4):1327-39. PubMed ID: 24437487
[TBL] [Abstract][Full Text] [Related]
30. Interaction between the insulin-like growth factor family and the integrin receptor family in tissue repair processes. Evidence in a rabbit ear dermal ulcer model.
Galiano RD; Zhao LL; Clemmons DR; Roth SI; Lin X; Mustoe TA
J Clin Invest; 1996 Dec; 98(11):2462-8. PubMed ID: 8958208
[TBL] [Abstract][Full Text] [Related]
31. Purification and characterization of the insulin-like growth factor-binding protein-1 phosphoform found in normal plasma.
Westwood M; Gibson JM; White A
Endocrinology; 1997 Mar; 138(3):1130-6. PubMed ID: 9048619
[TBL] [Abstract][Full Text] [Related]
32. Substitution of specific amino acids in insulin-like growth factor (IGF) binding protein 5 alters heparin binding and its change in affinity for IGF-I response to heparin.
Arai T; Clarke J; Parker A; Busby W; Nam T; Clemmons DR
J Biol Chem; 1996 Mar; 271(11):6099-106. PubMed ID: 8626396
[TBL] [Abstract][Full Text] [Related]
33. Increased IGFBP-1 phosphorylation in response to leucine deprivation is mediated by CK2 and PKC.
Malkani N; Biggar K; Shehab MA; Li SS; Jansson T; Gupta MB
Mol Cell Endocrinol; 2016 Apr; 425():48-60. PubMed ID: 26733150
[TBL] [Abstract][Full Text] [Related]
34. Glycosylation of insulin-like growth factor binding protein-3 (IGFBP-3) is not required for potentiation of IGF-I action: evidence for processing of cell-bound IGFBP-3.
Conover CA
Endocrinology; 1991 Dec; 129(6):3259-68. PubMed ID: 1720092
[TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
[TBL] [Abstract][Full Text] [Related]
36. Identification of the major sites of phosphorylation in IGF binding protein-3.
Hoeck WG; Mukku VR
J Cell Biochem; 1994 Oct; 56(2):262-73. PubMed ID: 7530253
[TBL] [Abstract][Full Text] [Related]
37. Insulin-like growth factor binding protein-3 leads to insulin resistance in adipocytes.
Chan SS; Twigg SM; Firth SM; Baxter RC
J Clin Endocrinol Metab; 2005 Dec; 90(12):6588-95. PubMed ID: 16189260
[TBL] [Abstract][Full Text] [Related]
38. Insulin-like growth factor (IGF)-binding proteins inhibit the smooth muscle cell migration responses to IGF-I and IGF-II.
Gockerman A; Prevette T; Jones JI; Clemmons DR
Endocrinology; 1995 Oct; 136(10):4168-73. PubMed ID: 7545099
[TBL] [Abstract][Full Text] [Related]
39. Site specific phosphorylation of insulin-like growth factor binding protein-1 (IGFBP-1) for evaluating clinical relevancy in fetal growth restriction.
Abu Shehab M; Inoue S; Han VK; Gupta MB
J Proteome Res; 2009 Nov; 8(11):5325-35. PubMed ID: 19731965
[TBL] [Abstract][Full Text] [Related]
40. Identification of the sites of phosphorylation in insulin-like growth factor binding protein-1. Regulation of its affinity by phosphorylation of serine 101.
Jones JI; Busby WH; Wright G; Smith CE; Kimack NM; Clemmons DR
J Biol Chem; 1993 Jan; 268(2):1125-31. PubMed ID: 7678248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
